Log In
Print
BCIQ
Print
Print this Print this
 

IV Captisol-enabled Melphalan

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionPropylene glycol-free melphalan delivered via Captisol sulfobutylether beta-cyclodextrin technology
Molecular Target DNA
Mechanism of ActionAlkylating agent
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today